Volume | 1,603,280 |
|
|||||
News | - | ||||||
Day High | 77.81 | Low High |
|||||
Day Low | 76.12 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Hologic Inc | HOLX | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
76.54 | 76.12 | 77.81 | 77.19 | 76.22 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
27,060 | 1,603,280 | $ 77.26 | $ 123,865,906 | - | 64.02 - 87.88 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
17:00:00 | 8 | $ 77.31 | USD |
Hologic (HOLX) Options Flow Summary
Hologic Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
18.12B | 234.73M | - | 4.05B | 456M | 1.94 | 39.75 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Hologic News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical HOLX Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 77.82 | 78.04 | 74.53 | 75.33 | 1,568,821 | -0.63 | -0.81% |
1 Month | 75.64 | 79.22 | 74.53 | 76.79 | 1,615,500 | 1.55 | 2.05% |
3 Months | 75.00 | 79.22 | 71.25 | 75.26 | 1,803,943 | 2.19 | 2.92% |
6 Months | 68.09 | 79.22 | 64.02 | 72.78 | 1,832,556 | 9.10 | 13.36% |
1 Year | 84.19 | 87.88 | 64.02 | 74.67 | 1,743,717 | -7.00 | -8.31% |
3 Years | 74.56 | 87.88 | 59.78 | 73.15 | 1,752,356 | 2.63 | 3.53% |
5 Years | 42.99 | 87.88 | 26.49 | 65.49 | 1,902,473 | 34.20 | 79.55% |
Hologic Description
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (64% of total sales, boosted by pandemic), breast health (21% of sales, suppressed by pandemic), surgical (12%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (75%), followed by Europe (16%), Asia (6%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts. |